Sugi Predict

Sugi Predict / Compounds / SCHEMBL25508997

SCHEMBL25508997

SCHEMBL25508997

COC(=O)[C@@H](N)CCC(=O)N1CCN(C(=O)OC(C)(C)C)Cc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.43
▸ NAMPT P43490 3/20 0.43
▸ NOTUM Q6P988 4/20 0.43
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NR1H2 P55055 2/20 0.39
▸ GPR119 Q8TDV5 1/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ PRMT5 O14744 1/20 0.38
▸ WDR77 Q9BQA1 1/20 0.38
▸ LIPG Q9Y5X9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25184866 0.87 NOTUM (0.46) MAPK1NOTUMMAPTMEN1KMT2A
SCHEMBL25264460 0.87 NOTUM (0.46) MAPK1NOTUMMAPTMEN1KMT2A
SCHEMBL23849039 0.83 MAPK1 (0.44) MAPK1NAMPTNOTUMMAPTMEN1
SCHEMBL25509005 0.82 BACE1 (0.46) NOTUM
SCHEMBL25508218 0.77 NOTUM (0.55) MAPK1NOTUMMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL30420292 0.77 NOTUM (0.54) MAPK1NOTUMMAPTMEN1KMT2A
SCHEMBL25508267 0.76 NOTUM (0.47) MAPK1NOTUMMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL30420089 0.75 NOTUM (0.46) MAPK1NOTUMMAPTMEN1KMT2A
SCHEMBL25212254 0.73 NR1H2 (0.47) NAMPTNR1H2GPR119HDAC6
SCHEMBL25212252 0.73 NR1H2 (0.47) NAMPTNR1H2GPR119HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151034-A1 PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-18 — — US disclosed
US-20230151034-A1 PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-18 — — US disclosed
US-20230151034-A1 PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151034-A1 PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION ASNS, GLUL, GNMT MAPK1 901/4885NAMPT 1934/4885NOTUM 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.